Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

Haifa, Israel and Miami (ots/PRNewswire) -

INSIGHTEC®, a commercial-stage medical technology company
revolutionizing surgery with incisionless MR-guided focused
ultrasound (MRgFUS) announced today that the Neuravive focused
ultrasound treatment will be a covered service for essential tremor
patients in Israel.

The Neuravive treatment is a non-invasive solution for patients
suffering from essential tremor who do not respond to medication.
During the Neuravive treatment, focused ultrasound beams are
delivered deep in the brain, with no incisions. The beams converge at
the part of the brain responsible for tremor, heating and destroying
the tissue. MRI is used for real-time imaging and temperature
monitoring. The result for many patients is immediate tremor relief.

"MR-guided Focused Ultrasound is a revolutionary technology with
positive outcomes for essential tremor patients," said Prof. Rafael
Beyar MD, General Director and CEO of Rambam Medical Campus, Israel.
"During the last three years, over sixty patients at Rambam have been
treated by a multidisciplinary team of a neurologist, neurosurgeon,
neuro-radiologist and a neurophysiologist with good results. I am
very proud of the global recognition we have received with this
breakthrough technology," he concluded.

"We are very proud by the Israeli Ministry of Health's decision to
include Neuravive in its list of services covered by public health
insurance," said Prof. Sharon Hassin-Baer, MD, Neurologist and the
Head of the Movement Disorders Institute at the Sheba Medical Center,
in Ramat Gan, Israel. "Now that the financial barrier has been
lifted, a growing number of patients will have access to this
important, restorative, non-invasive treatment."

"We are excited that Israel is the first national healthcare
system to include the Neuravive treatment in its health services plan
and are confident that the momentum will continue worldwide," said
Maurice R. Ferré, MD, INSIGHTEC's Chief Executive Officer and
Chairman of the Board.

"We are proud that INSIGHTEC was founded in Israel and today
employs 200 scientists, engineers and developers at the headquarters
in Israel," commented Eyal Zadicario, INSIGHTEC Chief Operating
Officer and General Manager in Israel.

Essential tremor, a neurological condition, causes uncontrollable
shaking of the hands and may also include shaking of the head, neck
or voice. The tremor can interfere with a person's ability to work
and perform daily activities including writing, dressing and eating.

The Neuravive treatment is available in Israel at the Rambam
Healthcare Campus in Haifa and Sheba Medical center in Ramat Gan.

About INSIGHTEC

INSIGHTEC is the world leader and innovator of MRI-guided Focused
Ultrasound. The company's non-invasive therapy platforms, Exablate
and Exablate Neuro, are proven technology based on sound clinical
evidence for treating essential tremor, painful bone metastases and
uterine fibroids. The company is dedicated to improving patient lives
by collaborating with physicians, medical institutions, academic
researchers and regulatory bodies around the world. INSIGHTEC is
headquartered in Haifa, Israel, and Miami, with offices in Dallas,
Tokyo and Shanghai.

"Exablate," as well as the "INSIGHTEC" logo, whether standing
alone or in connection with the word "INSIGHTEC" are protected
trademarks of INSIGHTEC.

For more information, please visit: www.insightec.com

Media Contact:

Michelle Barry

Red Lorry Yellow Lorry for INSIGHTEC

insightec@rlyl.com

+1-(857)-217-2886

ots Originaltext: InSightec
Im Internet recherchierbar: http://www.presseportal.de

Original-Content von: InSightec, übermittelt durch news aktuell